In our in vivo study, after 14 weeks of the induction of 75% renal mass reduction and the development of mild uremia with increases in BUN, PTH and renal levels of ADAM17 (an enzyme that increases in kidney disease of all etiologies) [23], no changes in serum Ca or P levels were observed. The gene discussed is ADAM17; the disease is kidney disorder.